Treatment
-
A ‘Revolution’ in Cancer ResearchAACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Black Patients Less Likely to Receive Targeted RadiationStudy finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
-
Forward Look
Be Clear About Treatment GoalsPeople with late-stage cancer must ask what they want from treatment.
by Tyler Santora
-
Forward Look
Women, Men and Treatment Side EffectsStudy shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
by Delia O'Hara
-
From the Editor-in-Chief
Cancer and AgingCancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
How Common Are Treatment Breakthroughs?A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
